245765-41-7
245765-41-7
Chemical Structure
Ozenoxacin
Synonym(s): T-3912
- CAS No.: 245765-41-7
- Formula:C21H21N3O3
- Molecular Weight:363.41
IUPAC Name: 1-cyclopropyl-8-methyl-7-(5-methyl-6-(methylamino)pyridin-3-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
InChIKey: XPIJWUTXQAGSLK-UHFFFAOYSA-N
SMILES: O=C(C1=CN(C2CC2)C3=C(C=CC(C4=CC(C)=C(NC)N=C4)=C3C)C1=O)O
Biological Activity: Ozenoxacin is a nonfluorinated quinolone antibacterial, which shows potent activities against the main microorganisms isolated from skin and soft tissue infections.
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Ozenoxacin | 99.48% | Ozenoxacin is a nonfluorinated quinolone antibacterial, which shows potent activities against the main microorganisms isolated from skin and soft tissue infections. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Ozenoxacin (Standard) | ≥98% | Ozenoxacin (Standard) is the analytical standard of Ozenoxacin. This product is intended for research and analytical applications. Ozenoxacin is a nonfluorinated quinolone antibacterial, which shows potent activities against the main microorganisms isolated from skin and soft tissue infections. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Ozenoxacin-d3 | Ozenoxacin-d3 is the deuterium-labeled Ozenoxacin (HY-14957). Ozenoxacin-d3 is a nonfluorinated quinolone antibacterial, which shows potent activities against the main microorganisms isolated from skin and soft tissue infections. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Ozenoxacin-d3 hydrochloride | ≥99.0% | Ozenoxacin-d3 (hydrochloride) is the deuterium labeled Ozenoxacin hydrochloride. Ozenoxacin hydrochloride is a nonfluorinated quinolone antibacterial, which shows potent activities against the main microorganisms isolated from skin and soft tissue infections. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
